http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 VILLA GUARDIA, Italy, June 26, 2008 -- Gentium S.p.A. (NASDAQ: GENT) (the "Company") today reported financial results for the quarter ended March 31, 2008. Highlights of the first quarter of 2008 and... http://pharmalicensing.com/redirs/news_rss//public/news/view/428909/3/gentium-reports-first-quarter-financial-results-provides-financial-and-clinical-update http://pharmalicensing.com/redirs/news_rss//public/news/view/428909/3/gentium-reports-first-quarter-financial-results-provides-financial-and-clinical-update Heidelberg, 26 June 2008 - SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today reports its financial results for the period ended 31 March 2008. Fiscal year 2007/2008 was one... http://pharmalicensing.com/redirs/news_rss//public/news/view/428932/3/sygnis-reports-full-year-financial-results-and-reviews-a-year-of-solid-progress http://pharmalicensing.com/redirs/news_rss//public/news/view/428932/3/sygnis-reports-full-year-financial-results-and-reviews-a-year-of-solid-progress London, UK, 26 June, 2008 - Lipoxen PLC (AIM:LPX), a bio-pharmaceutical company specialising in the development of high value differentiated biologicals, vaccines and oncology drugs, announces today... http://pharmalicensing.com/redirs/news_rss//public/news/view/428937/3/financial-results-for-the-12-months-ended-31-december-2007 http://pharmalicensing.com/redirs/news_rss//public/news/view/428937/3/financial-results-for-the-12-months-ended-31-december-2007 KAILUA KONA, Hawaii (June 26, 2008) -- Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in producing high-value nutrition and health products from microalgae, today announced... http://pharmalicensing.com/redirs/news_rss//public/news/view/428848/3/cyanotech-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-2008 http://pharmalicensing.com/redirs/news_rss//public/news/view/428848/3/cyanotech-reports-financial-results-for-the-fourth-quarter-and-fiscal-year-2008 June 26, 2008-- Keele, UK: Cobra Biomanufacturing Plc (AIM: CBF), the international manufacturer of biopharmaceuticals, today announces its interim results for the six months ended 31 March 2008. http://pharmalicensing.com/redirs/news_rss//public/news/view/428863/3/interim-results-for-the-six-months-ended-31-march-2008 http://pharmalicensing.com/redirs/news_rss//public/news/view/428863/3/interim-results-for-the-six-months-ended-31-march-2008 St. Louis, MO - June 25, 2008 - KV Pharmaceutical Company (NYSE: KVa/KVb), a fully integrated specialty pharmaceutical company that develops, manufactures, acquires and markets technology... http://pharmalicensing.com/redirs/news_rss//public/news/view/428879/3/kv-pharmaceutical-company-completes-fiscal-2008-filings-with-securities-and-exchange-commission http://pharmalicensing.com/redirs/news_rss//public/news/view/428879/3/kv-pharmaceutical-company-completes-fiscal-2008-filings-with-securities-and-exchange-commission June 25, 2008 -- Comment from Monsanto Chairman, President and Chief Executive Officer Hugh Grant: http://pharmalicensing.com/redirs/news_rss//public/news/view/428094/3/strong-results-in-roundup-seeds-and-traits-businesses-propel-monsanto-to-record-third-quarter-and-year-to-date-results http://pharmalicensing.com/redirs/news_rss//public/news/view/428094/3/strong-results-in-roundup-seeds-and-traits-businesses-propel-monsanto-to-record-third-quarter-and-year-to-date-results WILMINGTON, Mass.--June 25, 2008--CardioTech International, Inc. (AMEX: CTE), a leading developer and manufacturer of advanced biomaterials for a broad range of medical devices, today reported... http://pharmalicensing.com/redirs/news_rss//public/news/view/428077/3/cardiotech-international-reports-fiscal-2008-results http://pharmalicensing.com/redirs/news_rss//public/news/view/428077/3/cardiotech-international-reports-fiscal-2008-results June 24, 2008-Consort Medical (LSE: CSRT), a leader in medical devices for inhaled drug delivery and anaesthesia, today announces its preliminary results for the 53 weeks to 3 May 2008. http://pharmalicensing.com/redirs/news_rss//public/news/view/428028/3/consort-medical-plc-final-results-part-1 http://pharmalicensing.com/redirs/news_rss//public/news/view/428028/3/consort-medical-plc-final-results-part-1 WARSAW, Ind., June 24, 2008 -- Symmetry Medical Inc. (NYSE: SMA), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today first... http://pharmalicensing.com/redirs/news_rss//public/news/view/428043/3/symmetry-medical-reports-record-first-quarter-2008-revenue-of-101-9-million http://pharmalicensing.com/redirs/news_rss//public/news/view/428043/3/symmetry-medical-reports-record-first-quarter-2008-revenue-of-101-9-million